Brokerage houses have issued fresh ratings and target price updates for several key stocks, making them the focus for investors and traders today, November 7. Here’s a complete look at the latest brokerage calls tracked by Kunvarji.
Jefferies on TCI Express: Maintains Buy rating, raises target price to ₹950 per share. (Positive)
Elara on Astral: Maintains Buy, raises target price to ₹1,650 per share. (Positive)
DAM Capital on UPL: Maintains Buy, revises target price to ₹850 per share. (Positive)
Jefferies on Godrej Properties: Maintains Buy with a target of ₹3,000 per share, while Elara retains Buy with a higher target of ₹3,700 per share. (Positive)
Nomura on Cummins India: Maintains Buy, raises target price to ₹4,500 per share. (Positive)
Morgan Stanley on Bajaj Housing Finance: Maintains Overweight, sets target price at ₹1,150 per share. (Positive)
Citi on Apollo Hospitals: Maintains Buy with a target price of ₹9,330 per share; Morgan Stanley maintains Overweight with ₹8,058 per share. (Positive)
Morgan Stanley on Metropolis: Maintains Equal Weight, target price at ₹2,317 per share. (Positive)
Nomura on Lupin: Maintains Buy, raises target price to ₹2,350 per share. (Positive)
Citi on L&T Finance: Maintains Buy, raises target price to ₹330 per share. (Positive)
Citi on LIC: Maintains Buy but cuts target price to ₹1,345 per share. (Positive)
Jefferies on Mankind Pharma: Maintains Buy, cuts target price to ₹3,000 per share. (Neutral)
Jefferies on Amber Enterprises: Maintains Buy, target price at ₹9,500 per share. (Neutral)
Jefferies on Crompton: Maintains Buy, cuts target price to ₹410 per share; Goldman Sachs retains Buy at ₹330, while Morgan Stanley maintains Equal Weight with ₹310 per share. (Neutral)
Citi on Devyani International: Maintains Buy, cuts target price to ₹182 per share. (Neutral)
HSBC on Aurobindo Pharma: Maintains Buy, target price at ₹1,315 per share. (Neutral)
JP Morgan on Amara Raja Energy: Maintains Neutral, target price at ₹1,125 per share. (Neutral)
JP Morgan on Eternal: Maintains Overweight, target price at ₹390 per share. (Neutral)
UBS on ABB India: Maintains Neutral, target price at ₹5,360 per share. (Neutral)
Elara on Alkyl Amines: Maintains Reduce, cuts target price to ₹1,825 per share. (Neutral)
Morgan Stanley on India Strategy: For the firm’s coverage universe, revenue is up 8% YoY, EBITDA up 12% YoY, and net profit up 13% YoY. (Neutral)
These updates highlight strong optimism from top brokerages around Apollo Hospitals, Godrej Properties, Lupin, Cummins India, Astral, Bajaj Housing, and L&T Finance, making them key stocks to watch in Thursday’s session.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
